Skip to content

For laboratory and research use only. Not for human or veterinary use.

Blend

Retatrutide + Tirzepatide

Lot-matched COA · Third-party tested

20 mg + 40 mg blend. >99% HPLC.

  • ≥99% purity spec
  • ≤0.05 EU/mg endotoxin
  • USP <71> — 14-day incubation
  • Lot-matched COA

$190

The documentation guarantee Released against a ≥99% chromatographic purity specification, identity confirmed by mass spectrometry, with a Certificate of Analysis carrying the vial's own lot number.
  • Certificate of Analysis published for every released lot
  • Same-day dispatch on orders before 2:00 PM CT
  • Free shipping over $250
  • Unmarked packaging — no product names outside

SKU DEV-RETA-TIRZ

20 mg + 40 mg blend. >99% HPLC.

Supplied as a laboratory reference material. Store as indicated on the vial label and consult the lot Certificate of Analysis for solvent guidance.

Retatrutide

Analytical specification for Retatrutide
CAS number2381089-83-2
Molecular formulaC221H342N46O68
Average molecular weight4,731.40 g/mol
Amino-acid count39
Peptide classlipidated 39-residue peptide analogue
Physical formLyophilized powder
Research areaMetabolic research
SolubilitySoluble in sterile or bacteriostatic water; consult the lot COA for solvent guidance

Tirzepatide

Analytical specification for Tirzepatide
CAS number2023788-19-2
Molecular formulaC225H348N48O68
Average molecular weight4,813.45 g/mol
Amino-acid count39
Peptide classlipidated 39-residue peptide analogue
Physical formLyophilized powder
Research areaMetabolic research
SolubilitySoluble in sterile or bacteriostatic water; consult the lot COA for solvent guidance